IFNG and colitis: These results are inconsistent with reports that PPARs negatively regulate IFN-γ and presents an essential question: how may PPAR ligands modulate the overexpression of IFN-γ in a Th1 model of colitis and upregulate IFN-γ in Th2 colitis?